Hung CF - Search Results

1

HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions.

Peng S, Trimble C, Wu L, Pardoll D, Roden R, Hung CF, Wu TC. Peng S, et al. Among authors: hung cf. Clin Cancer Res. 2007 Apr 15;13(8):2479-87. doi: 10.1158/1078-0432.CCR-06-2916. Clin Cancer Res. 2007. PMID: 17438108 Free PMC article.

2

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors.

Ji H, Wang TL, Chen CH, Pai SI, Hung CF, Lin KY, Kurman RJ, Pardoll DM, Wu TC. Ji H, et al. Among authors: hung cf. Hum Gene Ther. 1999 Nov 20;10(17):2727-40. doi: 10.1089/10430349950016474. Hum Gene Ther. 1999. PMID: 10584920

3

Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene.

Chen CH, Wang TL, Hung CF, Yang Y, Young RA, Pardoll DM, Wu TC. Chen CH, et al. Among authors: hung cf. Cancer Res. 2000 Feb 15;60(4):1035-42. Cancer Res. 2000. PMID: 10706121

4

Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines.

Chen CH, Wang TL, Hung CF, Pardoll DM, Wu TC. Chen CH, et al. Among authors: hung cf. Vaccine. 2000 Apr 3;18(19):2015-22. doi: 10.1016/s0264-410x(99)00528-9. Vaccine. 2000. PMID: 10706963 Free article.

5

Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments.

Cheng WF, Hung CF, Hsu KF, Chai CY, He L, Ling M, Slater LA, Roden RB, Wu TC. Cheng WF, et al. Among authors: hung cf. Hum Gene Ther. 2001 Feb 10;12(3):235-52. doi: 10.1089/10430340150218387. Hum Gene Ther. 2001. PMID: 11177561

6

Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand.

Hung CF, Hsu KF, Cheng WF, Chai CY, He L, Ling M, Wu TC. Hung CF, et al. Cancer Res. 2001 Feb 1;61(3):1080-8. Cancer Res. 2001. PMID: 11221836

7

Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen.

Hung CF, Cheng WF, Chai CY, Hsu KF, He L, Ling M, Wu TC. Hung CF, et al. J Immunol. 2001 May 1;166(9):5733-40. doi: 10.4049/jimmunol.166.9.5733. J Immunol. 2001. PMID: 11313416

8

Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene.

Chen CH, Wang TL, Ji H, Hung CF, Pardoll DM, Cheng WF, Ling M, Wu TC. Chen CH, et al. Among authors: hung cf. Gene Ther. 2001 Jan;8(2):128-38. doi: 10.1038/sj.gt.3301370. Gene Ther. 2001. PMID: 11313782

9

Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen.

Hsu KF, Hung CF, Cheng WF, He L, Slater LA, Ling M, Wu TC. Hsu KF, et al. Among authors: hung cf. Gene Ther. 2001 Mar;8(5):376-83. doi: 10.1038/sj.gt.3301408. Gene Ther. 2001. PMID: 11313814

10

Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen.

Hung CF, Cheng WF, Hsu KF, Chai CY, He L, Ling M, Wu TC. Hung CF, et al. Cancer Res. 2001 May 1;61(9):3698-703. Cancer Res. 2001. PMID: 11325841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

668 results

Search Page

Filters